Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer
Li Jun Di(National Cancer Institute), Kevin Gardner(Columbia University Irving Medical Center), Howard H. Yang(Vanderbilt University), Tara Taylor(National Cancer Institute), C. Ryan Miller(University of North Carolina at Chapel Hill), Sven Bilke(Illumina (United States)), Cecilia Zvosec(University of Chicago), Rachel Raab(East Carolina University), Galina Khramtsova(University of Chicago), Clay Wakano(National Cancer Institute), Kent W. Hunter(National Cancer Institute), Olufunmilayo I. Olopade(University of Chicago), Charles M. Perou(Segeberger Kliniken), Madeline Wong(National Cancer Institute), Jung S. Byun(National Cancer Institute), Cheng Fan(University of North Carolina at Chapel Hill), Songjoon Baek(National Institutes of Health), Maxwell Lee(National Cancer Institute)
Cited by 177
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k